SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,785.00    90.00 (1.34%)
Bid:
6,785.00
Ask:
6,790.00
Spread: 5.00 (0.074%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

13 May 2008 12:00

RNS Number : 3064U
Spirax-Sarco Engineering PLC
13 May 2008
 

Spirax-Sarco Engineering plc

Tuesday 13th May 2008 

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the four month period ended 30th April 2008, ahead of its Annual General Meeting today at 2.00 pm.

Trading

Overall market conditions have remained favourable in 2008. We have seen sustained business investment by our customers and we continue to benefit from good progress with our ongoing sales initiatives.

The organic revenue growth trend has continued from last year through into 2008. Growth was spread across all geographic regions for both the Spirax Sarco and Watson-Marlow Bredel businesses. The euro has strengthened considerably since late last year which, together with other currency movements elsewhere, has benefited the translation into sterling of total Group revenues by approximately 6% overall, with a larger benefit to operating profit.

Corporate Developments

The integration of Flexicon with our Watson-Marlow Bredel business is proceeding well following completion of the acquisition on 11th February 2008 for £14m. As previously reported, Marcus Steel retired as Chief Executive as of 31st March 2008, as did Peter Smith, Director and Company Secretary. On 1st April Mark Vernon, previously Chief Operating Officer, succeeded Marcus as Chief Executive and William Stebbings succeeded Peter as Company Secretary.

Financial position

The Group started the year with net cash of £16m and has subsequently paid an initial £11m consideration for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period and we continue to operate with a strong balance sheet. As anticipated, we expect capital expenditure this year to be well above normal levels mainly due to the new premises in China.

 

Outlook

In our preliminary statement in early March, we reported that 2008 had started well and that, assuming our global markets remained stable, we expected to produce another good performance in 2008. Trading so far this year confirms this expectation, although there remains uncertainty about the resilience of the global economy, and in particular North America. If current exchange rates prevail for the remainder of the year, sales and profits, particularly in Continental Europe, will also benefit from good exchange gains.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBGGDUCSBGGIX
Date   Source Headline
21st Jul 201510:18 amRNSListing Application
21st Jul 20158:41 amRNSDirector/PDMR Shareholding
9th Jul 20153:22 pmRNSNotice of Results
2nd Jul 201510:00 amRNSAcquisition
19th Jun 20153:00 pmRNSHolding(s) in Company
18th Jun 20153:30 pmRNSDirector/PDMR Shareholding
18th Jun 201512:22 pmRNSHolding(s) in Company
18th Jun 201511:48 amRNSHolding(s) in Company
12th Jun 20153:50 pmRNSShare Consolidation
11th Jun 201512:37 pmRNSAmendment to Official List & Share Consolidation
10th Jun 20153:55 pmRNSAdditional Listing
9th Jun 20153:54 pmRNSAdditional Listing
2nd Jun 20153:56 pmRNSDirector/PDMR Shareholding
11th May 20155:00 pmRNSResult of AGM
11th May 20157:00 amRNSAGM Statement
1st May 20154:27 pmRNSDirector/PDMR Shareholding
1st May 20154:11 pmRNSNotification of Release Date
23rd Apr 20155:56 pmRNSHolding(s) in Company
21st Apr 20153:51 pmRNSDirector/PDMR Shareholding
21st Apr 20157:00 amRNSQueen's Award for Enterprise
9th Apr 20158:34 amRNSAcquisition
30th Mar 20155:05 pmRNSDirector/PDMR Shareholding
11th Mar 20154:29 pmRNSDirector/PDMR Shareholding
5th Mar 20157:01 amRNSSpirax Sarco to start direct operations in India
5th Mar 20157:00 amRNS2014 Preliminary Results
13th Jan 20154:12 pmRNSHolding(s) in Company
13th Jan 20154:11 pmRNSTotal Voting Rights
2nd Dec 201410:34 amRNSDirector/PDMR Shareholding
18th Nov 20144:08 pmRNSHolding(s) in Company
18th Nov 20144:07 pmRNSHolding(s) in Company
12th Nov 20144:41 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement
4th Nov 20144:13 pmRNSTotal Voting Rights
4th Nov 20144:13 pmRNSHolding(s) in Company
13th Oct 20144:59 pmRNSDirector/PDMR Shareholding
6th Oct 201411:57 amRNSTotal Voting Rights
1st Oct 201410:00 amRNSNotification of Key Date
22nd Sep 20145:15 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amRNSCET signs Heads of Terms with Spirax Sarco
4th Sep 20143:31 pmRNSTotal Voting Rights
28th Aug 20144:25 pmRNSHolding(s) in Company
19th Aug 20144:14 pmRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSHalf Yearly Report
6th Aug 20142:13 pmRNSTotal Voting Rights
25th Jul 20142:05 pmRNSHolding(s) in Company
7th Jul 20143:25 pmRNSNotification of Key Dates
2nd Jul 20143:43 pmRNSTotal Voting Rights
25th Jun 20143:05 pmRNSHolding(s) in Company
23rd Jun 20148:49 amRNSHolding(s) in Company
12th Jun 20148:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.